Trial · NCT00542425
Results by group25
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 25
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Marker of Bone Metabolism, PINP | Placebo | -13.1 | Standard Deviation 26.47 | Percent change from baseline | |
| Change in Marker of Bone Metabolism, PINP | BA058 20 µg | 20.0 | Standard Deviation 61.05 | Percent change from baseline | |
| Change in Marker of Bone Metabolism, PINP | BA058 40 µg | 90.8 | Standard Deviation 116.92 | Percent change from baseline | |
| Change in Marker of Bone Metabolism, PINP | BA058 80 µg | 97.2 | Standard Deviation 123.88 | Percent change from baseline | |
| Change in Marker of Bone Metabolism, PINP | Teriparatide | 154.3 | Standard Deviation 213.07 | Percent change from baseline | |
| Change in Bone Mineral Density, Total Spine. | Placebo | 1.22 | Standard Deviation 3.211 | Percent change from baseline | |
| Change in Bone Mineral Density, Total Spine. | BA058 20 µg | 3.30 | Standard Deviation 2.068 | Percent change from baseline | |
| Change in Bone Mineral Density, Total Spine. | BA058 40 µg | 5.21 | Standard Deviation 4.427 | Percent change from baseline | |
| Change in Bone Mineral Density, Total Spine. | BA058 80 µg | 6.11 | Standard Deviation 3.744 | Percent change from baseline | |
| Change in Bone Mineral Density, Total Spine. | Teriparatide | 5.47 | Standard Deviation 4.218 | Percent change from baseline | |
| Change in Bone Mineral Density, Femoral Neck. | Placebo | 0.79 | Standard Deviation 4.797 | Percent change from baseline | |
| Change in Bone Mineral Density, Femoral Neck. | BA058 20 µg | 2.69 | Standard Deviation 4.022 | Percent change from baseline | |
| Change in Bone Mineral Density, Femoral Neck. | BA058 40 µg | 2.20 | Standard Deviation 4.406 | Percent change from baseline | |
| Change in Bone Mineral Density, Femoral Neck. | BA058 80 µg | 3.07 | Standard Deviation 4.175 | Percent change from baseline | |
| Change in Bone Mineral Density, Femoral Neck. | Teriparatide | 1.07 | Standard Deviation 4.564 | Percent change from baseline | |
| Change in Bone Mineral Density, Total Hip. | Placebo | 0.39 | Standard Deviation 3.053 | Percent change from baseline | |
| Change in Bone Mineral Density, Total Hip. | BA058 20 µg | 1.43 | Standard Deviation 2.639 | Percent change from baseline | |
| Change in Bone Mineral Density, Total Hip. | BA058 40 µg | 1.97 | Standard Deviation 3.699 | Percent change from baseline | |
| Change in Bone Mineral Density, Total Hip. | BA058 80 µg | 2.60 | Standard Deviation 3.488 | Percent change from baseline | |
| Change in Bone Mineral Density, Total Hip. | Teriparatide | 0.45 | Standard Deviation 3.925 | Percent change from baseline |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00542425/results